from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2913c/-

LFCtreatmentdescriptionclass of inhibitor

0.486

Amikacinug/mL Amikacintranslation

0.989

Cap5-10ug/mL Capreomycintranslation

0.997

Rox10-50 ug/mL Roxithromycintranslation

1.931

SM2-5 ug/mL Streptomycintranslation

1.246

Tet5-10 ug/mL Tetracyclinetranslation

-0.003

Rif0.2-5ug/mL Rifampicintranscription

-0.414

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.778

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.106

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.594

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.829

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.878

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.316

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.285

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.321

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.197

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.651

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.524

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.715

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.195

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.126

Nigericin50 uM Nigericinrespiration

1.611

TRC10-150 ug/mL Triclosanrespiration

1.093

TRZ10-25 ug/mL Thioridazinerespiration

2.997

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.601

menadione6-10 ug/mL Menadionerespiration

-0.201

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.461

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.543

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.772

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.514

NRP_1Non-replicating persistence stage 1dosRassociated

-0.445

Amp0.2mg/mL AmpicillincellWall

-0.444

Cephalexin20-100 ug/mL CephalexincellWall

0.064

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.253

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.342

EMB10-20 ug/mL EthambutolcellWall

-0.169

Eta12-40 ug/mL EthionamidecellWall

-0.098

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.267

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.591

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.509

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.502

BZA0.12 mg/mL BenzamidearomaticAmides

-0.395

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.423

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.500

H2O24 mM hydrogen peroxideDNAdamaging

-0.144

Levo10 ug/mL LevofloxacinDNAdamaging

-0.596

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.706

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.222

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.225

UVUV-irradiationDNAdamaging

-1.251

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.216

Antimycin12.5-50 ug/mL Antimycin A?

-0.227

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.093

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.485

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.401

PA8240.2-2 ug/mL PA-824?

-0.712

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.116

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.420

Verapamil50 uM Verapamil?

-0.028

mercaptoethanol2 mM 2-Mercaptoethanol?

0.242

methoxatin10-20 ug/mL Methoxatin?